Pediatric Lyme Disease—‘An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21
October 18 2021 - 3:11PM
Business Wire
Among the many health challenges facing children is the very
real threat of contracting Lyme disease as nearly 30% of the
estimated 476,000 people in the U.S. each year who are diagnosed
and treated for this disease are ages 0-19. In response to this
troubling fact, an important webinar focused on how Lyme disease
affects the pediatric population will be held on Thursday, Oct.
21.
The free webinar—titled Pediatric Lyme Disease: “An Epidemic
Within a Pandemic!”—is part of an ongoing series hosted by Quidel,
the California-based diagnostic health care manufacturer known for
successfully developing rapid diagnostic health solutions. The
program is being held in collaboration with the Global Lyme
Alliance. Registration is now available at
http://education.quidel.com/frontmatter/2591/1/Ped-Lyme.
Conducting the webinar will be Robert A. Dracker, M.D., medical
director at Summerwood Pediatrics and Infusacare Medical Services
in Liverpool, New York. Dr. Dracker currently serves as chair of
the heart, lung and cancer committee for the Medical Society of New
York State and is a board member of the Office of Professional
Conduct for the New York State Department of Health. Since 2014 he
has been a member of the Pediatric Advisory Committee of the FDA
and served as chairman of the committee from 2018-2019.
The Oct. 21 webinar will discuss how Lyme disease presents in
children (often flu-like symptoms including fever, chills, malaise
and headache), how it progresses and tick-exposure management. Also
discussed will be how to test for Lyme disease, including the
innovative Sofia® 2 Lyme FIA test. This revolutionary test provides
the patient and physician with indicative results within 15
minutes, as opposed to days, which has historically been the norm
(and during which time organisms can spread and become systemic).
It can be performed in the privacy of a doctor’s office or local
clinic, and it is the only test that can get results from a simple
finger prick of blood.
“Children, for the most part, are more engaged on a regular
basis than are adults in outside activities, which is why being on
guard and testing for Lyme disease is so important,” said Dr.
Dracker. “If left untreated, the bacteria that cause Lyme disease
can attack many systems of a child’s body, including the skin,
heart, nerves and joints. While each child is different, to a tick
they are all the same and are all just waiting to be bitten.
Parents need to be vigilant, and physicians need to be attuned so
children can enjoy the wonderment of being a child while remaining
safe and smart.”
Among those expected to attend the webinar are pediatricians,
representatives of physician office laboratories, urgent care
centers, and any other allied health professionals or health care
researchers interested in hearing the latest regarding the
prevalence of Lyme disease in children. The free, Oct. 21, webinar
will take place from noon to 1 p.m. (EDT). To register, visit
http://education.quidel.com/frontmatter/2591/1/Ped-Lyme.
About Quidel Corporation
Quidel Corporation (Nasdaq: QDEL) is a leading manufacturer of
diagnostic solutions at the point of care, delivering a continuum
of rapid testing technologies that further improve the quality of
health care throughout the globe. An innovator for over 40 years in
the medical device industry, Quidel pioneered the first
point-of-care test for influenza in 1999 and was the first to
market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted
brand names, Sofia®, Solana®, Lyra®, Triage® and QuickVue®,
Quidel’s comprehensive product portfolio includes tests for a wide
range of infectious diseases, cardiac and autoimmune biomarkers, as
well as a host of products to detect COVID-19. Quidel’s mission is
to provide patients with immediate and frequent access to highly
accurate, affordable testing for the good of our families, our
communities and the world. For more information about Quidel, visit
quidel.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211018005923/en/
Jim Yeager 818-264-6812 (mobile) jim@breakwhitelight.com
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From May 2024 to Jun 2024
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From Jun 2023 to Jun 2024